The crude chloroform extract from the stem bark of Sorocea trophoides (Moraceae) showed in-vitro inhibition of the cysteine protease cruzain. Activity-directed fractionation led to isolation of the novel 3-O-(3'-hydroxytetradecanoyl)lupeol as the inhibitory agent. The structure was elucidated by analysis of NMR spectra.
Chagas disease, caused by the parasitic protozoan Trypanosoma cruzi, currently afflicts about 18 million people in tropical and subtropical America [1a] . Current chemotherapeutics include benznidazole and nifurtimox, but these treatments cause severe side effects [1b, 1c] , so there is a need for new antitrypanosomal agents. The cysteine protease cruzain has been suggested to be a biochemical target for antiparasitic drug discovery [1c] .
As part of our research program in investigating the higher plants of Monteverde, Costa Rica, for pharmaceutical potential [2a] , we had screened the bark extract of Sorocea trophoides W.C. Burger (Moraceae) for cruzain inhibitory activity. The crude chloroform bark extract showed promising activity with an IC 50 of 192 (± 9) μg/mL. S. trophoides is an understory tree up to 10 m tall x 20 cm dbh; stipules 3-7 mm long, deciduous, leaving two short scars per node; leaves simple, alternate, distichous, glabrous with petiole to 2 cm, blade to 7 x 20 cm, apex with a long drip tip, base acute to obtuse, slightly unequal and asymmetric, margin crenate-serrate, lateral veins 6-10 per side, connected near margin, texture papery; dioecious; male inflorescences axillary, to 7 cm, an unbranched spike or branched at base, flowers 2-3 mm long, cream-white; female inflorescence axillary, 3-5 cm long, single spikes or branched at base, flowers 2-3 mm long, cream-white; fruit to 12 mm, subglobose, black, infructescence and pedicels elongating in fruit and becoming orange-red. This species ranges from Mexico to Panama. In Costa Rica it grows in wet evergreen forest at about 800 to 1500 m elevation.
The crude chloroform bark extract of S. trophoides was subjected to activity-directed preparative flash chromatography on a silica gel column, eluting with n-hexane/ethyl acetate, and the cruzain inhibitory compound (8.34 g, IC 50 = 53.0 (± 0.6) μg/mL) was isolated. NMR spectral analysis (supplementary data) indicated the compound to be a 3-hydroxy tetradecanoic acid ester of lupeol. The 1 H and 13 C NMR spectroscopic data are comparable to those seen for lupeol [2b,2c] and for methyl 3-hydroxytetradecanoate [2d]. Because compound 1 showed cruzain inhibitory activity, we tested lupeol itself and it showed comparable activity (IC 50 = 40.8 ± 7.6 μg/mL). 
NPC Natural Product Communications

